Table 3 Limitations that hinder the broad use of omics technologies in nanotoxicology
From: Role of omics techniques in the toxicity testing of nanoparticles
Independent from the technology | Technology linked |
|---|---|
Lack of standardization of particle exposure | Request for high sample quality (freezing, protection against degradation) |
 Sample pre-treatment | Expertise in bioinformatics needed for data analysis |
 Cell type used for testing | Lack of standardization of sample preparation |
 Medium composition | Predictive value of the omics techniques not entirely clear |
Relevant concentration range | Â |